Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.
Thomas Keck
Part of the Pharmacology, Toxicology and Environmental Health Commons
Part of the Pharmacology, Toxicology and Environmental Health Commons